Introduction:

We do not have experience on the use of intranasal dexmedetomidine for gynecological procedures in the environment.

Objectives:

To demonstrate the effects of intranasal use of dexmedetomidine in sedation for obstetric gynecological procedures.

Methods:

a prospective, longitudinal, single-blind, uncontrolled clinical trial was conducted; Taking 24 patients from a universe of 80 patients, 0.9 pg/kg of intranasal dexmedetomidine was administered prior to performing the procedure. it was processed in IBM-SPPS v.25 ®. Calculation of mean and SD in quantitative and p value < 0.05 significant.

Results:

average age of 32 years old; basal heart rate 70 beats / min, being significant after induction and at the end of the procedure; the mean arterial pressure remained between 82 to 73 mmHg, not significant;Visual Numeric Scale was found from 0 in 18 patients; during induction and maintenance with Target Control Infusion it was found between 2 ng / ml of remifentanil and 2 mcg / ml of propofol. There were no complications in 18 patients.

Conclusions:

it provides hemodynamic stability at the dose used without adverse effects after administration of dexmedetomidine and produces a reduction in the doses of induction and maintenance drugs.